These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 31352863)
1. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy. Zhang W; Ren Y; Li J Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863 [No Abstract] [Full Text] [Related]
2. Improvement of membranous nephropathy by inhibition of miR-193a to affect podocytosis via targeting WT1. Li J; Chen Y; Shen L; Deng Y J Cell Biochem; 2019 Mar; 120(3):3438-3446. PubMed ID: 30242881 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy. Wu L; Zhang X; Luo L; Li X; Liu Y; Qin X J Clin Lab Anal; 2021 Apr; 35(4):e23737. PubMed ID: 33745222 [TBL] [Abstract][Full Text] [Related]
4. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1. Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161 [TBL] [Abstract][Full Text] [Related]
5. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy. Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017 [TBL] [Abstract][Full Text] [Related]
6. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers. Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145 [TBL] [Abstract][Full Text] [Related]
7. The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy. Tang Z; Wang Y; Tao L; Guo Y; Zheng Y; Zheng D BMC Nephrol; 2018 Dec; 19(1):357. PubMed ID: 30541470 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents. Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834 [TBL] [Abstract][Full Text] [Related]
9. A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia. Li H; Xing C; Zhou B; Ye H; Feng J; Wu J; Gao S Exp Hematol; 2018 May; 61():59-68.e5. PubMed ID: 29452230 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617 [TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Gebeshuber CA; Kornauth C; Dong L; Sierig R; Seibler J; Reiss M; Tauber S; Bilban M; Wang S; Kain R; Böhmig GA; Moeller MJ; Gröne HJ; Englert C; Martinez J; Kerjaschki D Nat Med; 2013 Apr; 19(4):481-7. PubMed ID: 23502960 [TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Urinary Exosomal miRNA in Idiopathic Membranous Nephropathy and Evaluation of its Diagnostic Value. Guo S; Hao H; Li S; Zhang L; Li R Tohoku J Exp Med; 2022 Apr; 256(4):327-336. PubMed ID: 35296567 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome. Zapata-Benavides P; Arellano-Rodríguez M; Bollain-Y-Goytia JJ; Franco-Molina MA; Rangel-Ochoa GA; Avalos-Díaz E; Herrera-Esparza R; Rodríguez-Padilla C Biomed Res Int; 2017; 2017():9531074. PubMed ID: 28299339 [TBL] [Abstract][Full Text] [Related]
14. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy. Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621 [TBL] [Abstract][Full Text] [Related]
16. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy. Hong Y; Wang J; Zhang L; Sun W; Xu X; Zhang K Ann Clin Biochem; 2021 Mar; 58(2):141-148. PubMed ID: 33302703 [TBL] [Abstract][Full Text] [Related]
17. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
18. [Idiopathic membranous nephropathy with focal segmental sclerosis]. Kamyshova ES; Bobkova IN; Kakhsurueva PА; Abdulaeva AS; Rudenko TЕ; Stavrovskaya EV; Andreeva EY; Li OА; Suvorov AY Ter Arkh; 2024 Jul; 96(6):580-586. PubMed ID: 39106498 [TBL] [Abstract][Full Text] [Related]
19. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy. Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902 [TBL] [Abstract][Full Text] [Related]
20. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study. Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]